CSF neurogranin or tau distinguish typical and atypical Alzheimer disease

OBJECTIVE: To assess whether high levels of cerebrospinal fluid neurogranin are found in atypical as well as typical Alzheimer's disease. METHODS: Immunoassays were used to measure cerebrospinal fluid neurogranin in 114 participants including healthy controls (n = 27), biomarker‐proven amnestic...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Ann Clin Transl Neurol
Autors principals: Wellington, Henrietta, Paterson, Ross W., Suárez‐González, Aida, Poole, Teresa, Frost, Chris, Sjöbom, Ulrika, Slattery, Catherine F., Magdalinou, Nadia K., Lehmann, Manja, Portelius, Eric, Fox, Nick C., Blennow, Kaj, Zetterberg, Henrik, Schott, Jonathan M.
Format: Artigo
Idioma:Inglês
Publicat: John Wiley and Sons Inc. 2018
Matèries:
Research Articles
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5817822/
https://ncbi.nlm.nih.gov/pubmed/29468177
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/acn3.518
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars